115. The Future of Therapy Is Psychedelic

She is one of the best basketball players ever. She’s won multiple championships, including four Olympic gold medals and four W.N.B.A. titles — the most recent in 2020, just before turning 40. She also helped negotiate a landmark contract for the league’s players. Sue Bird tells ...  Show more

For many economists — Steve Levitt included — there is perhaps no greater inspiration than Paul Romer, the now-Nobel laureate who at a young age redefined the discipline and has maintained a passion for introducing new ideas to staid debates. Levitt finds out what makes Romer a s ...  Show more

In the ‘80s and ‘90s, MDMA (also known as molly or ecstasy) was dismissed as a club drug and became the target of anti-drug propaganda. Today, it’s on the brink of being legalized for use in clinical therapy to treat conditions like PTSD. How did that happen? And what have we lea ...  Show more

Professor Paul Gilbert is a Clinical Psychologist at the University of Derby and honorary visiting Prof at the University of Queensland. He retired from the NHS in 2016 after over 40 years as a Consultant Clinical Psychologist. He has researched evolutionary approaches to psychop ...  Show more

How can you summon courage when you’re terrified? Is hiking more dangerous than skiing? And what is the stupidest thing that Mike has ever done?

Welcome to PsychEd, the psychiatry podcast for medical learners, by medical learners. This episode covers psychedelic-assisted psychotherapy with Dr Emma Hapke and Dr Daniel Rosenbaum, both of whom are psychiatrists at the University Health Network in Toronto and co-founders of U ...  Show more